Carbidine

CAS No. 33162-17-3

Carbidine( Carbidin | Carbidine dihydrochloride | Karbidin | Karbidine )

Catalog No. M27760 CAS No. 33162-17-3

Carbidine is an atypical neuroleptic compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 33 In Stock
5MG 28 In Stock
10MG 40 In Stock
25MG 65 In Stock
50MG 91 In Stock
100MG 137 In Stock
200MG 184 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carbidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Carbidine is an atypical neuroleptic compound.
  • Description
    Carbidine is an atypical neuroleptic compound.(In Vivo):After the administration of Carbidine(5 mg/kg, i.p.), the maximal IFC of Carbidine was found to be approximately 1 mu M 20-40 min after injection. Carbidine(1 mu M, i.p.) produces elevation of dopamine release not affecting sufficiently its metabolite dialysate levels. Carbidine(0.2 and 0.5 mg/kg, i.p.) stimulated locomotor activity of non-operated rats.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Carbidin | Carbidine dihydrochloride | Karbidin | Karbidine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    33162-17-3
  • Formula Weight
    275.22
  • Molecular Formula
    C13H20Cl2N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.Cl.CN1CCC2Nc3ccc(C)cc3C2C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ting Ran, et al. In Silico Discovery of JMJD6 Inhibitors for Cancer Treatment. ACS Med Chem Lett. 2019 Nov 19.
molnova catalog
related products
  • Daidzein-4-glucoside

    Daidzein-4'-glucoside is a natural product for research related to life sciences.

  • KL-22

    KL-22

  • Crenulatin

    Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.